Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
29.02.24
/
50%
€11.80
Target price
28.02.25
€20.36
Performance (%)
-19.92%
Price
03.10.24
€9.45
Summary
This prediction is currently active. The prediction for Amicus Therapeutics Inc. disappoints with a performance of -19.92%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -0.526% | -0.526% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $22.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
20.09.24
20.09.24
€17.90
20.09.25
20.09.25
-5.50%
03.10.24
03.10.24